Trial Profile
A crossover study assessing the pharmacokinetics, pharmacodynamics, and safety of recombinant human insulin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2007
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Baxter Healthcare Corporation
- 03 Nov 2006 New trial record.